Literature DB >> 2889203

Morphological studies on the effect of taxol on cultured human prostatic cancer cells.

M Röyttä1, K M Laine, P Härkönen.   

Abstract

The effect of taxol, an experimental antitumor drug, was studied in vitro on human prostatic cancer cells. Different concentrations of taxol, varying from 5 microM to 0.01 nM, were used. The effect of taxol was examined by light and electron microscopy. Taxol had a marked cytotoxic effect on prostatic cancer cells down to a 10 nM concentration of taxol when observed by light microscopy. However, by electron microscopy, the specific effect of taxol was seen even with a 1 nM concentration of taxol. Taxol induced the appearance of numerous round cells after a few days and, subsequently, progressive death of the tumor cells. Among the surviving tumor cells, large tumor cells were noted as well as many multinucleated tumor cells. By electron microscopy, the round tumor cells showed mitotic figures with a high amount of cytoplasmic microtubules. Nonmitotic cells were often multinucleated and contained a high number of cytoplasmic microtubules and microtubule-related structures. The results show that taxol, even at very low concentrations, has a highly cytotoxic effect on prostatic cancer cells; and when a very low concentration of taxol is used with no obvious cytotoxic effect at the light microscopic level, specific taxol-induced ultrastructural alterations can be observed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2889203     DOI: 10.1002/pros.2990110112

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  6 in total

1.  Breast cancer cells evade paclitaxel-induced cell death by developing resistance to dasatinib.

Authors:  Yun-Ji Jeong; Jong Soon Kang; Su In Lee; Dong Min So; Jieun Yun; Ji Young Baek; Sang Kyum Kim; Kiho Lee; Song-Kyu Park
Journal:  Oncol Lett       Date:  2016-07-13       Impact factor: 2.967

Review 2.  Oral chemotherapy in the treatment of hormone-refractory prostate cancer.

Authors:  K J Pienta; J M Kamradt; D C Smith
Journal:  Drugs       Date:  1999       Impact factor: 9.546

Review 3.  Paclitaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer.

Authors:  C M Spencer; D Faulds
Journal:  Drugs       Date:  1994-11       Impact factor: 9.546

4.  Cytotoxicity of taxol in vitro against human and rat malignant brain tumors.

Authors:  M A Cahan; K A Walter; O M Colvin; H Brem
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

5.  A Multi-center Study on the Reproducibility of Drug-Response Assays in Mammalian Cell Lines.

Authors:  Mario Niepel; Marc Hafner; Caitlin E Mills; Kartik Subramanian; Elizabeth H Williams; Mirra Chung; Benjamin Gaudio; Anne Marie Barrette; Alan D Stern; Bin Hu; James E Korkola; Joe W Gray; Marc R Birtwistle; Laura M Heiser; Peter K Sorger
Journal:  Cell Syst       Date:  2019-07-10       Impact factor: 10.304

6.  Synergistic interaction between cisplatin and taxol in human ovarian carcinoma cells in vitro.

Authors:  A P Jekunen; R D Christen; D R Shalinsky; S B Howell
Journal:  Br J Cancer       Date:  1994-02       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.